Skip to main content

Sumatriptan

NDC 76420-499 · Asclemed USA, Inc.

Generic nameSumatriptan Succinate
Dosage formTABLET
RouteORAL
Active ingredient(s)SUMATRIPTAN SUCCINATE
Strength25 mg/1
Pharmacologic classSerotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
Marketing categoryANDA

Packages

76420-499-09 — 9 TABLET in 1 BLISTER PACK (76420-499-09)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71205-251 — sumatriptan succinate, 71205-274 — sumatriptan succinate, 72189-404 — Sumatriptan, 72189-432 — Sumatriptan Succinate, 72189-433 — Sumatriptan Succinate, 72189-596 — Sumatriptan Succinate, 72485-518 — Sumatriptan, 72603-141 — Sumatriptan Succinate, 76420-093 — Sumatriptan Succinate, 76420-498 — Sumatriptan Succinate, 76420-500 — Sumatriptan Succinate, 80425-0224 — Sumatriptan, 80425-0258 — Sumatriptan, 80425-0318 — Sumatriptan, 80425-0475 — Sumatriptan, 82804-169 — Sumatriptan, 83270-005 — sumatriptan, 83270-151 — sumatriptan, 83270-152 — sumatriptan, 83270-156 — sumatriptan, +93 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels